GLP-1 medications like semaglutide and tirzepatide are expensive at full retail price, often exceeding $1,000 per month. But several legitimate paths exist to bring that cost down dramatically or even eliminate it, depending on your income and situation. Here’s a practical breakdown of every option available to you right now.
Manufacturer Savings Programs
Both major GLP-1 manufacturers offer savings programs specifically designed for people paying out of pocket. These are the fastest way to cut costs without jumping through many hoops.
Eli Lilly sells Zepbound (tirzepatide) directly through its LillyDirect self-pay program. The starting dose (2.5 mg) costs $349 for a one-month supply. Higher doses run $499 per month if you refill within 45 days of your previous delivery. Miss that window, and prices jump significantly: $599 for 7.5 mg up to $1,049 for the highest 15 mg dose. So staying on schedule matters.
Novo Nordisk’s Wegovy savings program covers people with and without insurance. It can bring your cost down to as little as $25 per month, with up to $1,000 off each fill. Eligibility requirements apply, and the discount may vary depending on the pharmacy and your specific situation. Both programs are worth checking before you explore anything else, since they use FDA-approved medications at predictable prices.
Patient Assistance Programs for Low-Income Households
If your household income is modest, you may qualify for free medication through the manufacturers’ patient assistance programs. These aren’t savings cards. They provide the actual drug at no cost.
Novo Nordisk’s Patient Assistance Program covers uninsured patients whose total household income falls at or below 200% of the federal poverty level for Ozempic. For most other Novo Nordisk medications, the threshold is 400% of the federal poverty level. You must be a U.S. citizen or legal resident to qualify. For context, 200% of the federal poverty level for a single person in 2025 is roughly $31,000 per year.
Eli Lilly’s assistance program (Lilly Cares) has historically set its income threshold at 300% of the federal poverty level. Eligibility details can shift year to year, so check directly with Lilly for the most current requirements for Zepbound or Mounjaro. The application process for both manufacturers typically involves your prescribing provider submitting paperwork on your behalf, along with proof of income.
Compounded Versions
Compounded GLP-1 medications are custom-mixed versions made by specialized pharmacies. They generally cost $200 to $500 per month, which represents a significant discount over brand-name retail prices. Many telehealth platforms now prescribe compounded semaglutide or tirzepatide as their primary offering for cash-pay patients.
There are real trade-offs to understand here. Compounded drugs are not FDA-approved. They don’t go through the same testing for safety, effectiveness, and manufacturing quality that brand-name drugs do. The FDA has flagged serious concerns with some compounded GLP-1 products, including dosing errors, use of unapproved chemical forms, and adverse events that required hospitalization.
The legal landscape is also shifting. Under federal law, compounding pharmacies can only produce copies of commercially available drugs under limited circumstances. Outsourcing facilities (larger-scale compounding operations) are restricted from using bulk semaglutide or tirzepatide ingredients unless those drugs appear on the FDA’s shortage list or a specific approved-use list. Neither semaglutide nor tirzepatide currently appears on either list. Individual compounding pharmacies operating under a different legal framework can fill a limited number of prescriptions per month, but only when a prescriber documents a specific clinical reason that the compounded version differs meaningfully from the commercial product.
If you go this route, verify that your pharmacy is a licensed, U.S.-based operation registered with the FDA or your state board of pharmacy. Avoid any source that doesn’t require a prescription.
Telehealth Platforms
Online health platforms have become one of the most common entry points for people seeking GLP-1s without insurance. They bundle the prescriber visit, ongoing monitoring, and sometimes the medication itself into a monthly subscription.
Ro charges $145 per month for its weight management membership. Hims & Hers runs $149 per month after an introductory rate of $39 for the first month. These fees typically cover the virtual consultations and care coordination, but the cost of the medication itself may be separate or bundled depending on the plan and whether you’re prescribed a brand-name or compounded product. Read the fine print carefully before signing up, because the total monthly cost (membership plus medication) is what actually matters to your budget.
The upside of these platforms is convenience: you can get evaluated, prescribed, and have medication shipped to your door without visiting a clinic. The downside is that many of them primarily prescribe compounded versions, which carry the risks described above.
Generic GLP-1 Medications
The FDA approved the first generic version of liraglutide (the active ingredient in Victoza) in December 2024, granted to Hikma Pharmaceuticals. A generic of exenatide (the active ingredient in Byetta) was approved shortly before that. These are older GLP-1 medications originally developed for type 2 diabetes rather than weight loss, and they work through the same receptor pathway as newer drugs like semaglutide.
Liraglutide requires daily injections rather than the weekly dosing of semaglutide or tirzepatide, and clinical data shows it produces more modest weight loss. Still, a generic version will likely cost substantially less than brand-name options once supply stabilizes. The FDA has noted that liraglutide is currently in shortage, so availability may be limited depending on when you’re looking. Contact the manufacturer or check with your pharmacy for current stock.
No generic versions of semaglutide or tirzepatide exist yet. Those patents won’t expire for several more years.
Using FSA or HSA Funds
If you have a flexible spending account or health savings account through your employer, prescription GLP-1 medications are eligible expenses. This includes the medication itself, provider visits, supplies, and shipping. You’ll need a valid prescription from a licensed provider, and your plan administrator may require receipts for reimbursement.
This doesn’t reduce the sticker price, but it lets you pay with pre-tax dollars, effectively saving you 20% to 35% depending on your tax bracket. If you’re planning to pay out of pocket for the year, adjusting your FSA contribution during open enrollment can make a meaningful dent in the real cost.
What to Avoid
The FDA has established a “green list” import alert specifically targeting unverified foreign sources of GLP-1 ingredients entering the U.S. market. Purchasing semaglutide or tirzepatide from overseas pharmacies, online marketplaces, or sources that don’t require a prescription puts you at risk of receiving counterfeit, contaminated, or incorrectly dosed products. Ingredients from unapproved sources are now subject to detention at the border without physical examination.
Any website selling injectable GLP-1 medications without requiring a prescription from a U.S.-licensed provider is operating outside the law. The financial savings aren’t worth the safety risk when legitimate lower-cost options exist.